BioNexus Gene Lab (BGLC) said it is partnering with ML Tech to optimize its Ethereum-focused treasury strategy.
The company said it plans to leverage ML Tech's digital asset trading infrastructure to grow its Ethereum holdings. ML Tech is a wealth management platform for digital assets.
Shares of the company were up over 3% in recent trading.
Price: 0.36, Change: +0.01, Percent Change: +3.77
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.